RADIATION THERAPY ONCOLOGY GROUP
RTOG 0921
A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) with Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients with Endometrial Cancer
RTOG 0921
A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) with Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients with Endometrial Cancer
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire
-
RPC Phantom Dosimetry Test
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- Contact Bill Straube at (314) 362-9762 regarding submission of phantom treatment planning data to the ITC.
- Data Submission
- Please see the RPC website to submit the Gynecological Brachytherapy Protocol Compliance Form. (Click on "Forms" on the homepage, and select Gynecological Brachytherapy Protocol Compliance Form). All optional brachy data, including hard copy film, as well as full AND empty bladder scans are to be mailed directly to the RPC. Call 713-745-8989 with any questions.
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- ATC Compliant Treatment Planning Systems
- Structure Names
- Gynecologic Pelvis Atlas
- Protocol Text (http://www.rtog.org/)
Back to protocols
